Mortality among patients with chronic kidney disease (CKD) is largely a consequence of
cardiovascular disease (CVD) and is a particular concern given the increasing prevalence of …

Diabetes mellitus (DM) is one of the most debilitating chronic diseases worldwide, with
increased prevalence and incidence. In addition to its macrovascular damage, through its …

Cardiovascular diseases (CVDs) continue to exert a significant impact on global mortality
rates, encompassing conditions like pulmonary arterial hypertension (PAH), atherosclerosis …

Diabetic nephropathy (DN) is a severe microvascular complication of diabetes, which
increases the risk of renal failure and causes a high global disease burden. Due to the lack …

Application of herbal medicines in the treatment of diseases is in the center of attention of
medical scientific societies. Saffron (Cricus sativus L.) is a medicinal plant belonging to the …

Diabetes mellitus (DM) belongs to the category of socially significant diseases with epidemic
rates of increases in prevalence. Diabetic nephropathy (DN) is a specific kind of kidney …

With the growing burden of metabolic disease, cardiovascular disease, and diabetes
mellitus, there is an implication for new pharmacological intervention. Sodium-glucose …

Aims: Inflammatory biomarkers may play vital roles in the pathophysiology of diabetes and
diabetic cardiorenal complications. Sodium-glucose cotransporter-2 (SGLT2) inhibitors have …

Diabetic kidney disease (DKD) has become the leading cause of end-stage renal disease
(ESRD), and the prevalence of DKD has increased worldwide during recent years. DKD is …

Diabetic kidney disease (DKD) is emerging rapidly as the leading cause of chronic kidney
disease (CKD) worldwide. In this 3-year prospective, multicenter cohort study, a total of 1138 …